Advertisement
News
Subscribe to MDT Magazine News

Cytotech Labs Unravels Hallmark Insight Into Metabolic Control of Cancer, Presents Work at Major AACR Cancer Meeting

April 4, 2011 12:33 pm | by Bio-Medicine.Org | Comments

ORLANDO, Fla., April 4, 2011 /- Cytotech Labs, a Boston based pharmaceutical company and member of the Berg Pharma, Inc. group along with Berg Biosystems and Berg Diagnostics today presented groundbreaking insight into seminal work performed by Nobel Laureate , Otto Warburg.  The...

TOPICS:

Adult-sized ATVs are not safe for kids; statistics startling

April 4, 2011 11:36 am | by EurekAlert | Comments

(American Academy of Orthopaedic Surgeons) All-terrain vehicles (ATVs) were introduced in this country in the 1970s. Currently, there are approximately 9.5 million ATVs in use and more than 150,000 reported ATV-related injuries in this country annually.

TOPICS:

Breckenridge Pharmaceutical Enters Agreement with Oman Pharmaceutical Products Company LLC

April 4, 2011 11:34 am | by Bio-Medicine.Org | Comments

BOCA RATON, Fla., April 4, 2011 /- Breckenridge is announcing that it entered into an agreement with Oman Pharmaceutical Products Company LLC, of Salalah, Sultanate of Oman to market Neomycin Sulfate Tablets. Under the terms of the agreement, the product will be manufactured by Oman...

TOPICS:
Advertisement

TPI Business and Development Profile Updated on OneMedDatabase

April 4, 2011 11:34 am | by Bio-Medicine.Org | Comments

CHENGDU, China, April 4, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI ), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals has...

TOPICS:

Hospira to Host Conference Call for First-Quarter 2011 Results

April 4, 2011 11:34 am | by Bio-Medicine.Org | Comments

LAKE FOREST, Ill., April 4, 2011 /- Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its first-quarter 2011 results on Tuesday, April 26, 2011 at 8 a.m. Central time. The...

TOPICS:

Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session

April 4, 2011 11:33 am | by Bio-Medicine.Org | Comments

NEW ORLEANS and CHAPEL HILL, N.C., April 4, 2011 /- Cardioxyl Pharmaceuticals, Inc. announced today that it is presenting two abstracts from studies of its lead clinical candidate, CXL-1020, at the American College of Cardiology's (ACC) 60th Annual Scientific Session & Expo in New...

TOPICS:

A GPS to locate missing Alzheimer's patients and battered women

April 4, 2011 10:37 am | by EurekAlert | Comments

(Carlos III University of Madrid) The Universidad Carlos III de Madrid is studying the development of a system based on satellite localization which can be used to find missing Alzheimer's patients and monitor battered women, as well as for inmate management in prisons.

TOPICS:

World Health Day is April 7 with a Focus on Antibiotic Resistance

April 4, 2011 9:36 am | by Bio-Medicine.Org | Comments

SAN DIEGO, April 4, 2011 /- Antibiotics are among the most important advances in human health, but their use and misuse over the past 70 years have increased the number and types of microorganisms resistant to antibiotics – resulting in deaths, greater suffering and disability, and...

TOPICS:
Advertisement

Heritage Provider Network Announces the Official Launch of the $3 million Dollar Heritage Health Prize

April 4, 2011 9:36 am | by Bio-Medicine.Org | Comments

MARINA DEL REY, Calif., April 4, 2011 /- Dr. Richard Merkin, President and CEO of Heritage Provider Network, announced today the official launch of the $3 million dollar Heritage Health Prize, the world's largest predictive modeling contest. In celebrating the launch of the contest at the...

TOPICS:

OncoGenex Announces Data Highlighting OGX-427 at American Association of Cancer Research (AACR) 102nd Annual Meeting 2011

April 4, 2011 9:36 am | by Bio-Medicine.Org | Comments

BOTHELL, Wash. and VANCOUVER, British Columbia, April 4, 2011 /- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that preclinical data utilizing their pipeline compound OGX-427 was presented at the AACR 102nd Annual Meeting 2011. The study demonstrated the ability of...

TOPICS:

Three Studies Presented at the 2011 SHEA Annual Scientific Meeting Show That the ICU Medical MicroCLAVE® Contributes to a Significant Decrease in Bacterial Transfer and Reduc...

April 4, 2011 9:35 am | by Bio-Medicine.Org | Comments

SAN CLEMENTE, Calif., April 4, 2011 /- ICU Medical, Inc. (NASDAQ: ICUI ) today announced that three different clinical studies presented at the Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (SHEA) April 1-4 in Dallas showed that the MicroCLAVE neutral...

TOPICS:

Boston Scientific's Promus Elementâ„¢ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Work...

April 4, 2011 9:33 am | by Boston Scientific | Comments

Reduction of geographic miss and bail-out stenting observed with highly visible PROMUS Element Stent

TOPICS:

AACR Inaugurates New Leadership

April 4, 2011 9:32 am | by AACR | Comments

Tweet • Judy E. Garber, M.D., M.P.H., is elected as the new president. • Nobel Laureate Elizabeth H. Blackburn, Ph.D., is past-president. • Frank McCormick, Ph.D., D.Sc. (hon.), is president-elect. ORLANDO, Fla. - Judy E. Garber, M.D., M.P.H., was inaugurated today as president of the...

TOPICS:

Patient's journey format drives new edition of vital student nurse manual

April 4, 2011 8:42 am | by EurekAlert | Comments

(Wiley-Blackwell) The eighth student edition of "The Royal Marsden Hospital Manual of Clinical Nursing Procedures" has just been launched, with an exciting new format that organizes 15 key chapters into four key stages of patient care. Although written primarily for UK students, it...

TOPICS:

Quest completes $740M acquisition of Athena Diagnostics

April 4, 2011 8:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Athena Diagnostics, a former Worcester business unit of Thermo Fisher Scientific Inc., has finalized its $740 million sale to Quest Diagnostics Inc. today.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading